| Immunovative 2012 news release |
|
Immunovative Therapies, Ltd. today announces speaking schedule for Dr. Michael Har-Noy, CEO and founder. Dr. Har-Noy will be giving a seminar at Johns Hopkins Institute for Cell Engineering on Wednesday February 14. On March 16, Dr. Har-Noy will be delivering the Plenary Lecture “Update on Tumor Immunology Concepts and Application to the Design of Effective Immunotherapies for Cancer” at The National Cancer Institute (NCI) of Thailand’s 11th National Cancer Conference entitled: “Bridging Cancer Research to Optimized Cancer Care and Control”.
The 2012 Annual Shareholders Meeting Announcement and Materials were set to all shareholders by email today. Any shareholders that did not receive a notice please send an email to: info@immunovative.co.il to update your email information and request your proxy materials. The annual meeting will be held January 24, 2012 in Herzliya and an informational meeting will be held on February 15 2012 in Carlsbad.
More News..
|
02/14/2012